Lipopeptide particles as the immunologically active component of CTL inducing vaccines

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 675-685

  Tsunoda, Ikuo ^a   Sette, Alessandro ^b   Fujinami, Robert S ^a   Oseroff, Carla ^b   Ruppert, Jorg ^b   Dahlberg, Carol ^b   Southwood, Scott ^b   Arrhenius, Thomas ^c   Kuang, Li Qing ^a   Kubo, Ralph T ^c   Chesnut, Robert W ^b   Ishioka, Glenn Y ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Epimmune   (United States)

^c CYTEL CORPORATION   (United States)

Author keywords

Antigen processing; Cytotoxic T lymphocytes; Lipopeptide particles

Indexed keywords

INFLUENZA VACCINE; LIPOPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL MIGRATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; IMMUNIZATION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLUENZA VACCINES; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MAST-CELL SARCOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; OVALBUMIN; PARTICLE SIZE; PEPTIDE FRAGMENTS; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRAL CORE PROTEINS;

EID: 0033605091     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00250-3     Document Type: Article

References (40)

1. Byrne J.A., Oldstone M.B.A. Biology of cloned cytotoxic T-lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:1984;682-686.
2. Yap K.L., Ada G.L., McKenzie I.F.C. Transfer of specific cytotoxic T-lymphocytes protects mice inoculated with influenza virus. Nature. 273:1978;238-239.
3. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A.S. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 309:1983;13-17.
4. Quinnan G.V., Kirmeni N., Rook A.H., Manishevitz J.V., Jackson L., Moreschi G., Santos G.W., Saral R., Burns W.H. Cytotoxic T-cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic response correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. Med. 307:1982;6-13.
5. Deres K., Schild H., Weismüller K.-H., Jung G., Rammensee H.-G. In vivo priming of virus-specific cytotoxic T-lymphocytes with synthetic lipopeptide vaccine. Nature. 342:1989;561-564.
6. Weismüller K.-H., Bessler W.G., Jung G. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper, and T-killer cell response. Int. J. Peptide Protein Res. 40:1992;255-260.
7. Allsopp C.E., Plebanski M., Gilbert S., Harris R.E., Frankel G., Dougan G., Hioe C., Nixon D., Paoletti E., Layton G., Hill A.V. Comparison of numerous delivery systems for the induction of cytotoxic T-lymphocytes by immunization. Eur. J. Immunol. 26:1996;1951-1959.
8. Hioe C.E., Qiu H., Chend P.D., Bian Z., Li M.L., Li J., Singh M., Kuebler P., McGee P., O'Hagan D., Zamb T., Koff W., Allsopp C., Yang C.Y., Nixon D.F. Comparison of adjuvant formulations for cytotoxic T-cell induction using synthetic peptides. Vaccine. 14:1996;412-418.
9. Benmohamed L., Gras-Masse H., Tartar A., Daubersies P., Brahimi K., Bossus M., Thomas A., Druilhe P. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper and cytotoxic T-lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol. 27:1997;1242-1253.
10. Vitiello A., Ishioka G., Grey H.M., Rose R., Farness P., LaFond R., Yuan L., Chisari F.V., Furze J., Bartholomeuz R., Chesnut R.W. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T-lymphocyte response in man. J. Clin. Invest. 95:1995;341-349.
11. Livingston B.D., Crimi C., Grey H., Ishioka G., Chisari F.V., Grey H., Chesnut R.W., Sette A. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol. 159:1997;1383-1392.
12. Sette A., Southwood S., O'Sullivan D., Gaeta F.C.A., Sidney J., Grey H.M. Effect of pH on MHC class II-peptide interactions. J. Immunol. 148:1992;844-851.
13. b-restricted epitopes. J. Immunol. 157:1996;5555-5562.
14. Sette A., Buus S., Colon S., Miles C., Grey H.M. Structural analysis of peptides capable of binding to more than one Ia antigen. J. Immunol. 142:1989;35-40.
15. Tsunoda I., Kurtz C.I., Fujinami R.S. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology. 228:1997;388-393.
16. Borrow P., Evans C.F., Oldstone M.B.A. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1995;1059-1070.
17. Austyn J.M., Gordon S. F4/80, a monoclonal antibody directed against the mouse macrophage. Eur. J. Immunol. 11:1981;805-815.
18. Metlay J.P., Witmer-Pack M.D., Agger R., Crowley M.T., Lawless D., Steinman R.M. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1990;1753-1771.
19. Kraal G., Breel M., Janse M., Bruin G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:1986;981-987.
20. Jiang W., Swiggard W.J., Heufler C., Peng M., Mirza A., Steinman R.M., Nussenzweig M.C. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 375:1995;151-155.
21. Duhamel R.C., Johnson D.A. Use of nonfat dry milk to block nonspecific nuclear and membrane staining by avidin conjugates. J. Histochem. Cytochem. 33:1985;711-714.
22. Rock K.L., Gamble S., Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science. 249:1990;918-921.
23. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA. 90:1993;4942-4946.
24. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:1994;4925-4933.
25. Svensson M., Stockinger B., Wick M.J. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T-cells. J. Immunol. 158:1997;4229-4236.
26. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1973;1142-1162.
27. Steinman R.M. The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol. 9:1991;271-296.
28. Inaba K., Inaba M., Naito M., Steinman R.M. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:1993;479-488.
29. Lanzavecchia A. Mechanisms of antigen uptake for presentation. Curr. Opin. Immunol. 8:1996;348-353.
30. Torres C.A.T., Iwasaki A., Barber B.H., Robinson H.L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:1997;4529-4532.
31. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T-lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA. 93:1996;8578-8583.
32. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2:1996;1122-1128.
33. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
34. Ulmer J.B., Deck R.R., Dewitt C.M., Donnhly J.I., Liu M.A. Generation of MHC class I-restricted cytotoxic T-lymphocytes by expression of a viral protein in muscle cells: antigen presentation by nonmuscle cells. Immunology. 89:1996;59-67.
35. Song E.S., Lee V., Surh C.D., Lynn A., Brumm D., Jolly D.J., Warner J.F., Chada S. Antigen presentation in retroviral vector-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA. 94:1997;1943-1948.
36. Crowley M., Inaba K., Steinman R.M. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172:1990;383-386.
37. Macatonia S.E., Knight S.C., Edwards A.J., Griffiths S., Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166:1987;1654-1667.
38. Wolf B., Hauschildt S., Uhl B., Metzger J., Jung G., Bessler W.G. Localization of the cell activator lipopeptide in bone marrow-derived macrophages by electron loss spectroscopy (EELS). Immunol. Lett. 20:1989;121-126.
39. Swanson J.A. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J. Cell Sci. 94:1989;135-142.
40. Steinman R.M., Swanson J. Endocytic activity of dendritic cells. J. Exp. Med. 182:1995;283-288.